HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine
Kristen Marks(Cornell University), Raghd Alyatim(AIDS Clinical Trials Group), Dennis Dentoni-Lasofsky(AIDS Clinical Trials Group), Rosemarie Ramirez(AIDS Clinical Trials Group), Cecilia Rivas Alfaro(AIDS Clinical Trials Group), Hugo Perazzo(Fundação Oswaldo Cruz), Alex Hessel(AIDS Clinical Trials Group), Rachel Bender Ignacio, Ceora Beijer(AIDS Clinical Trials Group), Dawn Rosenblum(AIDS Clinical Trials Group), Stephanie Caruso(Frontier Science & Technology Research Foundation, Inc.), Shawn Chiambah(AIDS Clinical Trials Group), Anchalee Avihingsanon(Chulalongkorn University), Teresa Spitz(Washington University in St. Louis), Joyce Jones(Johns Hopkins University), Karen J. Vigil(Texas Medical Center), Kenneth E. Sherman(Harvard University), Patcharaphan Sugandhavesa(Chiang Mai University), Jennifer C. Price(University of California, San Francisco), Michael Leonard(AIDS Clinical Trials Group), Ruben Lopez(AIDS Clinical Trials Group), Oladapo Alli(AIDS Clinical Trials Group), Kevin Knowles(Frontier Science & Technology Research Foundation, Inc.), Jan Kosmyna(AIDS Clinical Trials Group), Cheryl Keenan(AIDS Clinical Trials Group), Triin Umbleja(Harvard University), Leonard Sowah(AIDS Clinical Trials Group), Sara Zabih, Leolin Katsidzira(University of Zimbabwe), Eric S. Daar(UCLA Medical Center), Aleen Khodabakhshian, Kim Epperson(AIDS Clinical Trials Group), Josphat Kosgei(United States Army Medical Research Directorate - Africa), Christina Vernon(AIDS Clinical Trials Group), Andrea L. Cox(Johns Hopkins University), Madhu Choudhary(University of Pittsburgh), Minhee Kang(Cancer Research And Biostatistics), M. Gustave Planchon(AIDS Clinical Trials Group), L. Lawrence Mark(AIDS Clinical Trials Group), Paul E. Sax(Brigham and Women's Hospital), Terence Mohammed(AIDS Clinical Trials Group), Françoise Giguel(Harvard University), Lillian Collins(AIDS Clinical Trials Group), Jen Sullivano(AIDS Clinical Trials Group), Katrina Shea(AIDS Clinical Trials Group), Beverly Alston‐Smith(Cancer Research And Biostatistics)
Cited by 4
Related Papers
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
|New England Journal of Medicine|2002|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
|Clinical Infectious Diseases|2001|680